SARCOLACTICUM ACIDUM 3C MD

Manufacturer
Boiron | Boiron, Inc.
Effective date
2026-04-27
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:38:25

Label at a glance#

ProductSARCOLACTICUM ACIDUM
Active ingredientLACTIC ACID, L-
Label structure11 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient** (in each pellet)

Sarcolacticum acidum 3C HPUS (0.44 mg)

The letters “HPUS” indicate that the component in this product is officially monographed in the Homeopathic Pharmacopoeia of the United States.

OTC - PURPOSE SECTION

Purpose*

Sarcolacticum acidum 3C HPUS (0.44 mg)………………….Relieves minor pain and stiffness from muscular overexertion

INDICATIONS & USAGE SECTION

Uses*

temporarily relieves symptoms from muscular overexertion such as:

▪ minor pain ▪ soreness ▪ stiffness ▪ muscle fatigue

OTC - STOP USE SECTION

Stop use and ask a doctor if symptoms persist for more than 3 days or worsen, new symptoms occur, or if redness or swelling is present. These could be signs of a serious condition.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Children under 12 years of age: Ask a doctor.

INACTIVE INGREDIENT SECTION

lactose, sucrose

OTC - QUESTIONS SECTION

BoironUSA.com

Info@Boiron.com

1-800-BOIRON-1 (1-800-264-7661)

SPL UNCLASSIFIED SECTION

do not use if glued carton end flaps are open or if pellet dispenser seal is broken

contains 0.25 g of sugar per dose

retain carton for full drug facts

Made in France

Distributed by Boiron Inc.

Newtown Square, PA 19073

SPORTS PAIN RELIEF*

Muscle Pain ▪ Stiffness

Soreness ▪ Muscle Fatigue*

3 TUBES

APPROX. 80 PELLETS EACH

TOTAL 240 PELLETS

1 TUBE

APPROX. 80 PELLETS


How to dispense pellets? Turn tube upside down. Twist until 5 pellets are dispensed into cap. Carefully remove the cap and use it to pour pellets under the tongue.
*CLAIMS BASED ON TRADITIONAL HOMEOPATHIC PRACTICE NOT ACCEPTED MEDICAL EVIDENCE. NOT FDA EVALUATED.
**C,K,CK, and X are homeopathic dilutions: see BoironUSA.com/info for details.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

labellabel

LABELLABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0220-4474-41SARCOLACTICUM ACIDUM3 [hp_C] in 1 TUBEPELLET34
0220-4474-43SARCOLACTICUM ACIDUM3 in 1 CARTONPELLET34

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0220-44740220-4474-41, 0220-4474-43

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SARCOLACTICUM ACIDUMLACTIC ACID, L-Boirondc019886-27cb-28f2-e053-2995a90a1be32026-04-27Exact identifier
ndc (package): 0220-4474-41
ndc (package): 0220-4474-43
ndc (product): 0220-4474
ndc11 (package): 00220447443
ndc11 (package): 00220447441
spl id: 50742175-1d77-214b-e063-6294a90ab842
spl set id: dc019886-27cb-28f2-e053-2995a90a1be3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.